ORIGINAL RESEARCH article
Front. Public Health
Sec. Health Economics
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1614647
This article is part of the Research TopicChanging Healthcare through Innovation in Clinical Management and Healthcare Policy Strategies: Focus on Quality Improvement for the PatientView all 5 articles
DRG Payment Does Not Predispose to Negative Clinical Outcomes in General Surgery Cases: Evidence From a Tertiary Hospital in China
Provisionally accepted
- Peking Union Medical College Hospital (CAMS), Beijing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Diagnosis-related group (DRG) payment has proven effective in improving efficiency and containing medical costs. However, concerns persist regarding its potential negative impact on healthcare quality. This study aimed to investigate the association of DRG payment with negative clinical outcomes in general surgery cases.The study utilized clinical and insurance data from patients undergoing elective general surgeries at authors' institution between March 2019 and February 2025, with the DRG payment officially implemented in March 2022.Changes in average costs and length of stay (LOS) before and after the DRG payment were assessed using t-tests. To evaluate the reform's impact on healthcare quality, interrupted time series analysis (ITSA) was applied to examine changes in the rates of five negative clinical outcomes: in-hospital mortality, unplanned readmission within 31 days, red blood cell transfusion exceeding 10 units, LOS exceeding 30 days, and unplanned reoperations.The sample included 38014 discharged cases, including 18666 cases before and 19348 cases after DRG implementation. Five groups with the highest case volumes were KD1 (thyroid surgery), GB2 (major operation of intestines and colorectum), HC2 (cholecystectomy), GB1 (major operation of stomach and duodenum), HB1 (major operation of pancreas and liver). Following DRG payment, significant reduction in costs was observed in GB2 and GB1, while significant reduction in LOS was observed in groups GB2, HC2 and HB1. ITSA revealed no significant changes in level or trend for any of the five negative clinical outcomes, either in the overall sample or in the subgroups.For patients undergoing general surgeries, DRG payment promoted efficiency without increasing the risk of negative clinical outcomes.
Keywords: DRG, General Surgery, negative clinical outcome, Unplanned reoperation, Inhospital mortality, Readmission
Received: 19 Apr 2025; Accepted: 28 Aug 2025.
Copyright: © 2025 Hou, Liu, Chen, Tan, Li, Wang and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rui Hou, Peking Union Medical College Hospital (CAMS), Beijing, China
Weiguo Zhu, Peking Union Medical College Hospital (CAMS), Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.